The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial. (Q51273562)
Jump to navigation
Jump to search
scientific article published on 7 February 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial. |
scientific article published on 7 February 2015 |
Statements
1 reference
The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial. (English)
1 reference
Shigeo Horie
1 reference
Satoru Muto
1 reference
Haruna Kawano
1 reference
Eiji Higashihara
1 reference
Ichiei Narita
1 reference
Yoshifumi Ubara
1 reference
Takayuki Matsuzaki
1 reference
John Ouyang
1 reference
Vicente E Torres
1 reference
7 February 2015
1 reference
19
1 reference
867-877
1 reference
5
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference